Scrip
Dr Bruce Carter joins Immune Design
24 November 2009
Zoe Dann
Please Login to read the full article.
24 November 2009
Zoe Dann
Dr Bruce Carter has joined Immune Design as executive chairman. He has experience in biotechnology executive management, having formerly served as CEO of ZymoGenetics, US, and chief scientific officer of Novo Nordisk, Denmark.
Please Login to read the full article.
RELATED CONTENT
NEWS
- 2009 Scrip Awards celebrate industry's achievements
- US FDA senior staff appointments reflect consumer advocacy and regulatory expertise
- GENova Biotherapeutics causes concern as media blitz culminates in stock trading suspension – update
- Former MedImmune execs raise $10 million for new start-up Zyngenia
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
